ERO1A and pancreatic neoplasm: Accordingly, western blot analysis of ERO1α expression in the treated cells confirmed that our gene disruption strategy achieved complete knockout of ERO1α protein (Figure 4C), so we proceeded to test whether pancreatic tumor cell proliferation rates differed between WT and ERO1α-KO clones.